Prediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learning

The theoretical prediction of drug-decorated nanoparticles (DDNPs) has become a very important task in medical applications. For the current paper, Perturbation Theory Machine Learning (PTML) models were built to predict the probability of different pairs of drugs and nanoparticles creating DDNP com...

ver descrição completa

Detalhes bibliográficos
Autores: Munteanu, Cristian Robert, Gutiérrez-Asorey, Pablo, Blanes-Rodríguez, Manuel, Hidalgo-Delgado, Ismael, Blanco Liverio, María de Jesús, Castiñeiras Galdo, Brais, Porto-Pazos, Ana B., Gestal, Marcos, Arrasate, Sonia, González-Díaz, Humberto
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/314201
Acesso em linha:http://hdl.handle.net/10261/314201
https://api.elsevier.com/content/abstract/scopus_id/85117883551
Access Level:acceso abierto
Palavra-chave:ChEMBL database
Anti-glioblastoma
Big data
Decorated nanoparticles
Drug delivery
Machine learning
Perturbation theory
Descrição
Resumo:The theoretical prediction of drug-decorated nanoparticles (DDNPs) has become a very important task in medical applications. For the current paper, Perturbation Theory Machine Learning (PTML) models were built to predict the probability of different pairs of drugs and nanoparticles creating DDNP complexes with anti-glioblastoma activity. PTML models use the perturbations of molecular descriptors of drugs and nanoparticles as inputs in experimental conditions. The raw dataset was obtained by mixing the nanoparticle experimental data with drug assays from the ChEMBL database. Ten types of machine learning methods have been tested. Only 41 features have been selected for 855,129 drug-nanoparticle complexes. The best model was obtained with the Bagging classifier, an ensemble meta-estimator based on 20 decision trees, with an area under the receiver operating characteristic curve (AUROC) of 0.96, and an accuracy of 87% (test subset). This model could be useful for the virtual screening of nanoparticle-drug complexes in glioblastoma. All the calculations can be reproduced with the datasets and python scripts, which are freely available as a GitHub repository from authors.